Navigation Links
Signalife Appoints Lee Ehrlichman President and Chief Operating Officer
Date:6/3/2008

LOS ANGELES, June 3 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) has announced that it has appointed Mr. Lee B. Ehrlichman -- who is already a member of the company's Board of Directors -- as President and Chief Operating Officer. In that capacity, Mr. Ehrlichman's primary focus, in addition to monitoring and supervising company operations, will be on sales and marketing of the company's products.

Mr. Ehrlichman, who pioneered outpatient real-time cardiac telemetry technology and call center monitoring as Chief Executive Officer and President of Cardiac Telecom Corporation, will report directly to Signalife's Chief Executive Officer, Mr. Rowland Perkins. Mr. Ehrlichman's successful history is known and is public record, including for example his stint at Tartan, Inc., a company which he turned around after ten-years of losses, and later was sold to Texas Instruments.

Signalife also announced that it has moved its principal headquarters to Los Angeles -- where it was originally based -- in-house with the company's laboratory, R&D and IT operations, and close to the company's manufacturing operations in Ventura, California. Signalife has also expanded the square footage of its Los Angeles facilities in view of numerous additional staff members the company envisions it will add in the coming days in connection with its anticipated sales and marketing activities.

Dr. Lowell T. Harmison, Signalife's prior Chief Executive Officer and President, has taken an indefinite leave of absence as both an officer and director during which he is expected to consult to the company, as best he can, on a variety of matters.

In view of such leave, Mr. Rowland Perkins, previously Signalife's Interim Administrative Chief Executive Officer, will assume all duties of the office of Chief Executive Officer. Rowland Perkins, Signalife's Chief Executive Officer, commented: "I am personally excited and gratified to have somebody of Lee Ehrlichman's exp
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Signalife Appoints Lee Ehrlichman as Company Director and Operations Director; Additional Notice Received From Amex Regarding Sharholders Equity Deficiency
2. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
3. Signalife Announces Webcast
4. AMEX Notifies Signalife That It Has Accepted Signalifes Plan of Compliance
5. Signalife Sees Accretive Purchase and Financial Commitments
6. Signalife Wins Second Frost & Sullivan Technology Award
7. Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
8. AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement
9. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
10. U.S. Patent 7,299,083 Awarded to Signalife
11. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... San Francisco, CA (PRWEB) April 16, 2015 ... is scheduled to report first quarter results on Thursday, ... the announcement, Cytokinetics’ senior management will host a conference ... and financial results and the company’s outlook for the ... and can be accessed from the homepage and in ...
(Date:4/16/2015)... 16, 2015 According to the ... an outside source was ranked first among the ... related to lifting, pushing, pulling, holding, carrying, or ... costs. The David Round Company takes statistics like ... working hard to develop and design equipment that ...
(Date:4/16/2015)... 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... joint venture with G-treeBNT (ReGenTree LLC) has retained ... trial for the orphan disorder, neurotrophic keratopathy (NK), ... eye syndrome (DES) in the U.S.  Both trials ... this year.  Each of these eye disorders was ...
(Date:4/16/2015)... Calif. , April 16, 2015  Scientists from ... "New Drugs on the Horizon," at the American Association ... Philadelphia, PA on Sunday, April 19, 2015 ... Ph.D., Cleave,s Director of Biology, will present new in ... a first-in-class, oral inhibitor of p97, a critical enzyme ...
Breaking Biology Technology:Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3
... will receive the Johnson & Johnson Dr. Paul Janssen Award ... a series of events that celebrate his central role in ... signaling molecule of angiogenesis. His research has opened the door ... combat a serious eye disorder and contributed to the development ...
... 13Researchers at Vanderbilt University have developed a new technique that ... tissue at multiple points simultaneously, a method that could help ... and change shape. UV lasers are a commonly-used ... incisions by vaporizing one point at a time in a ...
... 2011 Saladax Biomedical, Inc., a privately held company ... promise of personalized medicine for new and existing therapeutics, ... of Saladax, will be presenting at the Annual UBS ... York in New York City on Tuesday, September 20, ...
Cached Biology Technology:Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research 2Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research 3Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research 4Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research 5Saladax Biomedical, Inc. to Present at the Annual UBS Global Life Sciences Conference in New York City 2
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
... of poor rice farmers and consumers in Asia have received ... While the world's trading nations remain deadlocked on how to ... farmers of the developing world, research just published has confirmed ... planet's two most populous countries, China and India. , The ...
... damaged heart muscle tissue . . . regenerate injured bone ... . even reverse nerve damage. Human stem cells offer tremendous ... and a variety of other human health problems. , Up ... ethical controversy -- as well as by the rarity of ...
... emerged field of bacterial riboswitches may be a good ... to a report by Yale researchers in the journal ... control gene expression in essential metabolic pathways. Researchers in ... Henry Ford II Professor of Molecular, Cellular and ...
Cached Biology News:Some good news for the world's poor 2Some good news for the world's poor 3Some good news for the world's poor 4From one cell, many possible cures 2From one cell, many possible cures 3Switching to new anti-bacterial targets: Riboswitches 2
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
Mouse monoclonal antibody raised against a partial recombinant PRG4. NCBI Entrez Gene ID = PRG4...
... selection system for recombinant identification. Recombinant selection ... need for costly color screening. This quick ... accuracy in recombinant selection. pLivSelect is also ... This cloning kit is customized as ...
The F40 pump maintenance kit is used to service one F40 pump of a BioLogic DuoFlow workstation. It includes 2 piston seals, 4 check valves, seal removal tool, and 2 O-rings....
Biology Products: